샘플 요청 목록

 카트 문의
시장보고서
상품코드
2034209

의료용 콜라겐 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)

Medical Collagen Market Insights, Competitive Landscape, and Market Forecast - 2033
발행일: | 리서치사: 구분자 Fairfield Market Research | 페이지 정보: 영문 201 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



가격
Unprintable PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,995 금액 안내 화살표 ￦ 7,605,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.
US $ 8,495 금액 안내 화살표 ￦ 12,934,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,600 금액 안내 화살표 ￦ 16,139,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료용 콜라겐 시장은 의료 현장에서 치료 및 수술 용도로 생체 유래 재료가 점점 더 많이 채택됨에 따라 꾸준히 성장하고 있습니다. 결합 조직에 존재하는 기본 단백질인 콜라겐은 생체적합성, 구조적 강도 및 재생 능력으로 널리 알려져 있습니다. 콜라겐은 상처 치료, 성형외과 치료, 조직 공학 및 미용 시술에 광범위하게 활용되고 있습니다. 전 세계 의료 산업이 최소침습적 치료와 재생의료로 전환하는 가운데, 콜라겐을 주성분으로 하는 제품은 필수 불가결한 요소로 자리 잡고 있습니다. 생체재료공학의 지속적인 발전과 임상현장에서의 수용도가 높아짐에 따라 현대 의료현장에서 콜라겐의 역할은 더욱 강화되고 있습니다.

시장 인사이트

전 세계 의료용 콜라겐 시장 규모는 2026년에 4억 5,320만 달러에 달했으며, 2033년까지 6억 8,690만 달러로 성장할 것으로 예상되며, 예측 기간 동안 6.10%의 CAGR로 확대될 것으로 예상됩니다. 이러한 성장은 첨단 상처 치유 솔루션에 대한 수요 증가, 수술 건수 증가, 재생의료 분야에서의 응용 분야 확대에 힘입어 성장세를 보이고 있습니다. 시장 진입 기업들은 증가하는 임상적 요구에 부응하기 위해 제품 혁신, 가공 기술 향상, 안전성 프로파일 강화에 주력하고 있습니다. 또한, 콜라겐 기반 생체 재료는 치유를 촉진하고 조직 재생을 지원하며 회복 기간을 단축하는 능력이 있기 때문에 그 채택이 증가하고 있습니다.

촉진요인

만성 상처, 화상 및 수술로 인한 손상 발생률의 증가는 콜라겐 기반 의료 제품의 수요를 이끄는 주요 요인입니다. 콜라겐 드레싱과 스캐폴드는 치유를 촉진하고 합병증을 줄이는 데 매우 효과적이어서 의료진들이 선호하는 선택이 되고 있습니다. 또한, 고령화가 진행됨에 따라 노화에 따른 퇴행성 질환에 걸리기 쉬워지고 고도의 치료법이 필요하기 때문에 고령 인구의 증가가 시장 성장에 크게 기여하고 있습니다.

또 다른 주요 촉진요인은 미용 및 재건 수술 시장의 급속한 확대입니다. 콜라겐은 전 세계적으로 인기가 높아지고 있는 피부 필러 및 안면 재건 수술에 널리 사용되고 있습니다. 환자의 치료 결과 개선과 수술 위험 최소화에 대한 관심이 높아짐에 따라 콜라겐 기반 솔루션의 채택이 증가하고 있습니다. 또한, 생명공학 및 조직공학의 발전으로 기능성이 향상된 차세대 콜라겐 제품 개발이 가능해져 보다 폭넓은 응용 분야를 뒷받침하고 있습니다.

비즈니스 기회

의료용 콜라겐 시장은 제조업체와 투자자들에게 큰 성장 기회를 제공하고 있습니다. 기존의 동물성 원료에 대한 우려를 해소할 수 있는 재조합 및 합성 콜라겐의 개발이 유망한 분야로 떠오르고 있습니다. 이러한 첨단 대체품은 균일성, 안전성 및 확장성이 향상되어 대규모 의료 응용 분야에 적합합니다.

특히 아시아태평양과 라틴아메리카 등 신흥 경제권에서는 의료 인프라 개선, 의료비 증가, 첨단 치료법에 대한 인식이 높아지면서 큰 기회가 창출되고 있습니다. 이들 지역에서 사업 확장에 집중하는 기업들은 미개척 시장 잠재력의 혜택을 누릴 가능성이 높습니다.

또한, 콜라겐을 약물전달 시스템에 접목하려는 움직임이 활발해지고 있습니다. 콜라겐 기반 캐리어는 특히 만성 질환 및 종양 치료에서 약물의 제어된 방출과 표적 치료를 가능하게 합니다. 치과 치료 및 임플란트 치료에서의 콜라겐 활용 확대도 시장 확대를 위한 새로운 길을 열어가고 있습니다. 전략적 제휴, 합병, 연구 협력은 혁신을 촉진하고 시장에서의 입지를 강화하는 데 중요한 역할을 할 것으로 예상됩니다.

지역별 분석

북미는 탄탄한 의료 인프라, 높은 의료 기술 보급률, 주요 산업 플레이어의 강력한 존재감을 바탕으로 의료용 콜라겐 시장을 독점하고 있습니다. 이 지역은 혁신과 임상 연구 분야에서 지속적으로 선도적인 위치를 차지하고 있으며, 지속적인 시장 성장에 기여하고 있습니다.

유럽은 재생의료에 대한 수요 증가와 지원적인 규제 프레임워크에 힘입어 시장에서 큰 비중을 차지하고 있습니다. 독일, 프랑스, 영국 등의 국가는 강력한 연구 역량을 바탕으로 콜라겐 기반 의료 솔루션 도입에 있어 선두에 서 있습니다.

아시아태평양은 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다. 급속한 경제 발전, 의료 시스템의 확장, 그리고 선진 의료에 대한 인식이 높아지면서 이 지역의 성장을 주도하는 주요 요인이 되고 있습니다. 중국, 인도, 일본 등의 국가에서는 다양한 의료 용도에서 콜라겐 기반 제품에 대한 수요가 증가하고 있습니다.

라틴아메리카와 중동 및 아프리카는 의료 접근성 개선과 의료 인프라에 대한 투자 확대에 따라 점차 잠재적인 시장으로 부상하고 있습니다. 이들 지역은 현재 시장 점유율은 작지만, 업계 관계자들에게 장기적인 성장 기회를 제공하고 있습니다.

주요 기업

  • Collagen Solutions plc
  • DSM Biomedical
  • Integra LifeSciences Holdings Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc
  • Baxter International Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • CollPlant Biotechnologies Ltd.
  • Advanced BioMatrix, Inc.
  • Nitta Gelatin Inc.
  • Gelita AG
  • Rousselot
  • Koken Co., Ltd.

세분화

원료별

  • 소 콜라겐
  • 돼지 콜라겐
  • 해양 콜라겐
  • 가금류 콜라겐
  • 기타

제품 유형별

  • 젤라틴
  • 가수분해 콜라겐
  • 천연 콜라겐
  • 기타

물리적 형태별

  • 분말
  • 젤
  • 필름 및 시트
  • 서스펜션
  • 액체, 고체, 반고체

유형별

  • 주사용 콜라겐
  • 외용 콜라겐
  • 생체흡수성 콜라겐

최종사용자별

  • 병원·클리닉
  • 전문 클리닉
  • 제약·바이오 기업
  • 연구기관 및 CRO

지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

제3장 세계의 의료용 콜라겐 시장 전망, 2020-2033년

제4장 북미의 의료용 콜라겐 시장 전망, 2020-2033년

제5장 유럽의 의료용 콜라겐 시장 전망, 2020-2033년

제6장 아시아태평양의 의료용 콜라겐 시장 전망, 2020-2033년

제7장 라틴아메리카의 의료용 콜라겐 시장 전망, 2020-2033년

제8장 중동 및 아프리카의 의료용 콜라겐 시장 전망, 2020-2033년

제9장 경쟁 구도

제10장 부록

KSM 26.05.27

The medical collagen market is steadily advancing as healthcare systems increasingly adopt biologically derived materials for therapeutic and surgical applications. Collagen, a fundamental protein found in connective tissues, is widely recognized for its biocompatibility, structural strength, and regenerative properties. It is extensively used in wound care, orthopedic treatments, tissue engineering, and cosmetic procedures. As the global healthcare industry shifts toward minimally invasive treatments and regenerative medicine, collagen-based products are becoming indispensable. Continuous improvements in biomaterial engineering and rising clinical acceptance are further strengthening the role of collagen in modern medical practice.

Market Insights

The global medical collagen market is projected to reach US$ 453.2 million in 2026 and is expected to grow to US$ 686.9 million by 2033, expanding at a CAGR of 6.10% during the forecast period. This growth is driven by increasing demand for advanced wound healing solutions, rising surgical procedures, and expanding applications in regenerative medicine. Market players are focusing on product innovation, improved processing technologies, and enhanced safety profiles to meet growing clinical requirements. The adoption of collagen-based biomaterials is also rising due to their ability to accelerate healing, support tissue regeneration, and reduce recovery time.

Drivers

The increasing incidence of chronic wounds, burns, and surgical injuries is a major factor driving the demand for collagen-based medical products. Collagen dressings and scaffolds are highly effective in promoting faster healing and reducing complications, making them a preferred choice among healthcare professionals. Additionally, the growing geriatric population is contributing significantly to market growth, as aging individuals are more prone to degenerative diseases and require advanced treatment options.

Another key driver is the rapid expansion of the aesthetic and reconstructive surgery market. Collagen is widely used in dermal fillers and facial reconstruction procedures, which are gaining popularity globally. The rising focus on improving patient outcomes and minimizing surgical risks has increased the adoption of collagen-based solutions. Furthermore, advancements in biotechnology and tissue engineering are enabling the development of next-generation collagen products with enhanced functionality, supporting broader application areas.

Business Opportunity

The medical collagen market offers significant growth opportunities for manufacturers and investors. The development of recombinant and synthetic collagen is emerging as a promising area, addressing concerns related to traditional animal-derived sources. These advanced alternatives provide improved consistency, safety, and scalability, making them suitable for large-scale medical applications.

Emerging economies, particularly in Asia Pacific and Latin America, present substantial opportunities due to improving healthcare infrastructure, rising healthcare spending, and increasing awareness of advanced treatment options. Companies that focus on expanding their presence in these regions are likely to benefit from untapped market potential.

Additionally, the integration of collagen into drug delivery systems is gaining traction. Collagen-based carriers enable controlled drug release and targeted therapy, especially in chronic disease and oncology treatments. The growing use of collagen in dental procedures and implantology is also creating new avenues for market expansion. Strategic partnerships, mergers, and research collaborations are expected to play a crucial role in driving innovation and strengthening market positions.

Region Analysis

North America dominates the medical collagen market, supported by well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong presence of leading industry players. The region continues to lead in innovation and clinical research, contributing to sustained market growth.

Europe holds a significant share of the market, driven by increasing demand for regenerative therapies and supportive regulatory frameworks. Countries such as Germany, France, and the United Kingdom are at the forefront of adopting collagen-based medical solutions, supported by strong research capabilities.

Asia Pacific is anticipated to register the fastest growth during the forecast period. Rapid economic development, expanding healthcare systems, and increasing awareness about advanced medical treatments are key factors driving regional growth. Countries like China, India, and Japan are witnessing rising demand for collagen-based products across various medical applications.

Latin America and the Middle East & Africa are gradually emerging as potential markets, with improving healthcare access and increasing investments in medical infrastructure. Although these regions currently hold a smaller share, they offer long-term growth opportunities for industry participants.

Key Players

  • Collagen Solutions plc
  • DSM Biomedical
  • Integra LifeSciences Holdings Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc
  • Baxter International Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • CollPlant Biotechnologies Ltd.
  • Advanced BioMatrix, Inc.
  • Nitta Gelatin Inc.
  • Gelita AG
  • Rousselot
  • Koken Co., Ltd.

Segmentation

By Source

  • Bovine Collagen
  • Porcine Collagen
  • Marine Collagen
  • Poultry Collagen
  • Others

By Product Type

  • Gelatin
  • Hydrolyzed Collagen
  • Native Collagen
  • Others

By Physical Form

  • Powder
  • Gel
  • Films & Sheets
  • Suspensions
  • Liquid, Solid, Semi-solid

By Type

  • Injectable Collagen
  • Topical Collagen
  • Bioabsorbable Collagen

By End User

  • Hospitals & Clinics
  • Specialty Clinics
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes & CROs

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Collagen Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Medical Collagen Market Outlook, 2020 - 2033

  • 3.1. Global Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 3.1.1. Bovine Collagen
    • 3.1.2. Porcine Collagen
    • 3.1.3. Marine Collagen
    • 3.1.4. Poultry Collagen
    • 3.1.5. Others
  • 3.2. Global Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 3.2.1. Gelatin
    • 3.2.2. Hydrolyzed Collagen
    • 3.2.3. Native Collagen
    • 3.2.4. Others
  • 3.3. Global Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
    • 3.3.1. Powder
    • 3.3.2. Gel
    • 3.3.3. Films & Sheets
    • 3.3.4. Suspensions
    • 3.3.5. Liquid, Solid, Semi-solid
  • 3.4. Global Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
    • 3.4.1. Injectable Collagen
    • 3.4.2. Topical Collagen
    • 3.4.3. Bioabsorbable Collagen
  • 3.5. Global Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 3.5.1. Hospitals & Clinics
    • 3.5.2. Specialty Clinics
    • 3.5.3. Pharmaceutical & Biotechnology Companies
    • 3.5.4. Research Institutes & CROs
  • 3.6. Global Medical Collagen Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.6.1. North America
    • 3.6.2. Europe
    • 3.6.3. Asia Pacific
    • 3.6.4. Latin America
    • 3.6.5. Middle East & Africa

4. North America Medical Collagen Market Outlook, 2020 - 2033

  • 4.1. North America Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 4.1.1. Bovine Collagen
    • 4.1.2. Porcine Collagen
    • 4.1.3. Marine Collagen
    • 4.1.4. Poultry Collagen
    • 4.1.5. Others
  • 4.2. North America Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 4.2.1. Gelatin
    • 4.2.2. Hydrolyzed Collagen
    • 4.2.3. Native Collagen
    • 4.2.4. Others
  • 4.3. North America Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
    • 4.3.1. Powder
    • 4.3.2. Gel
    • 4.3.3. Films & Sheets
    • 4.3.4. Suspensions
    • 4.3.5. Liquid, Solid, Semi-solid
  • 4.4. North America Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
    • 4.4.1. Injectable Collagen
    • 4.4.2. Topical Collagen
    • 4.4.3. Bioabsorbable Collagen
  • 4.5. North America Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 4.5.1. Hospitals & Clinics
    • 4.5.2. Specialty Clinics
    • 4.5.3. Pharmaceutical & Biotechnology Companies
    • 4.5.4. Research Institutes & CROs
  • 4.6. North America Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.6.1. U.S. Medical Collagen Market Outlook, by Source, 2020-2033
    • 4.6.2. U.S. Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 4.6.3. U.S. Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 4.6.4. U.S. Medical Collagen Market Outlook, by Type, 2020-2033
    • 4.6.5. U.S. Medical Collagen Market Outlook, by End User, 2020-2033
    • 4.6.6. Canada Medical Collagen Market Outlook, by Source, 2020-2033
    • 4.6.7. Canada Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 4.6.8. Canada Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 4.6.9. Canada Medical Collagen Market Outlook, by Type, 2020-2033
    • 4.6.10. Canada Medical Collagen Market Outlook, by End User, 2020-2033
  • 4.7. BPS Analysis/Market Attractiveness Analysis

5. Europe Medical Collagen Market Outlook, 2020 - 2033

  • 5.1. Europe Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 5.1.1. Bovine Collagen
    • 5.1.2. Porcine Collagen
    • 5.1.3. Marine Collagen
    • 5.1.4. Poultry Collagen
    • 5.1.5. Others
  • 5.2. Europe Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 5.2.1. Gelatin
    • 5.2.2. Hydrolyzed Collagen
    • 5.2.3. Native Collagen
    • 5.2.4. Others
  • 5.3. Europe Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
    • 5.3.1. Powder
    • 5.3.2. Gel
    • 5.3.3. Films & Sheets
    • 5.3.4. Suspensions
    • 5.3.5. Liquid, Solid, Semi-solid
  • 5.4. Europe Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
    • 5.4.1. Injectable Collagen
    • 5.4.2. Topical Collagen
    • 5.4.3. Bioabsorbable Collagen
  • 5.5. Europe Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 5.5.1. Hospitals & Clinics
    • 5.5.2. Specialty Clinics
    • 5.5.3. Pharmaceutical & Biotechnology Companies
    • 5.5.4. Research Institutes & CROs
  • 5.6. Europe Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.6.1. Germany Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.2. Germany Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.3. Germany Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.4. Germany Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.5. Germany Medical Collagen Market Outlook, by End User, 2020-2033
    • 5.6.6. Italy Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.7. Italy Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.8. Italy Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.9. Italy Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.10. Italy Medical Collagen Market Outlook, by End User, 2020-2033
    • 5.6.11. France Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.12. France Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.13. France Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.14. France Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.15. France Medical Collagen Market Outlook, by End User, 2020-2033
    • 5.6.16. U.K. Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.17. U.K. Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.18. U.K. Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.19. U.K. Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.20. U.K. Medical Collagen Market Outlook, by End User, 2020-2033
    • 5.6.21. Spain Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.22. Spain Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.23. Spain Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.24. Spain Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.25. Spain Medical Collagen Market Outlook, by End User, 2020-2033
    • 5.6.26. Russia Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.27. Russia Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.28. Russia Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.29. Russia Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.30. Russia Medical Collagen Market Outlook, by End User, 2020-2033
    • 5.6.31. Rest of Europe Medical Collagen Market Outlook, by Source, 2020-2033
    • 5.6.32. Rest of Europe Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 5.6.33. Rest of Europe Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 5.6.34. Rest of Europe Medical Collagen Market Outlook, by Type, 2020-2033
    • 5.6.35. Rest of Europe Medical Collagen Market Outlook, by End User, 2020-2033
  • 5.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Medical Collagen Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 6.1.1. Bovine Collagen
    • 6.1.2. Porcine Collagen
    • 6.1.3. Marine Collagen
    • 6.1.4. Poultry Collagen
    • 6.1.5. Others
  • 6.2. Asia Pacific Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 6.2.1. Gelatin
    • 6.2.2. Hydrolyzed Collagen
    • 6.2.3. Native Collagen
    • 6.2.4. Others
  • 6.3. Asia Pacific Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
    • 6.3.1. Powder
    • 6.3.2. Gel
    • 6.3.3. Films & Sheets
    • 6.3.4. Suspensions
    • 6.3.5. Liquid, Solid, Semi-solid
  • 6.4. Asia Pacific Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
    • 6.4.1. Injectable Collagen
    • 6.4.2. Topical Collagen
    • 6.4.3. Bioabsorbable Collagen
  • 6.5. Asia Pacific Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Specialty Clinics
    • 6.5.3. Pharmaceutical & Biotechnology Companies
    • 6.5.4. Research Institutes & CROs
  • 6.6. Asia Pacific Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.6.1. China Medical Collagen Market Outlook, by Source, 2020-2033
    • 6.6.2. China Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 6.6.3. China Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 6.6.4. China Medical Collagen Market Outlook, by Type, 2020-2033
    • 6.6.5. China Medical Collagen Market Outlook, by End User, 2020-2033
    • 6.6.6. Japan Medical Collagen Market Outlook, by Source, 2020-2033
    • 6.6.7. Japan Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 6.6.8. Japan Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 6.6.9. Japan Medical Collagen Market Outlook, by Type, 2020-2033
    • 6.6.10. Japan Medical Collagen Market Outlook, by End User, 2020-2033
    • 6.6.11. South Korea Medical Collagen Market Outlook, by Source, 2020-2033
    • 6.6.12. South Korea Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 6.6.13. South Korea Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 6.6.14. South Korea Medical Collagen Market Outlook, by Type, 2020-2033
    • 6.6.15. South Korea Medical Collagen Market Outlook, by End User, 2020-2033
    • 6.6.16. India Medical Collagen Market Outlook, by Source, 2020-2033
    • 6.6.17. India Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 6.6.18. India Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 6.6.19. India Medical Collagen Market Outlook, by Type, 2020-2033
    • 6.6.20. India Medical Collagen Market Outlook, by End User, 2020-2033
    • 6.6.21. Southeast Asia Medical Collagen Market Outlook, by Source, 2020-2033
    • 6.6.22. Southeast Asia Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 6.6.23. Southeast Asia Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 6.6.24. Southeast Asia Medical Collagen Market Outlook, by Type, 2020-2033
    • 6.6.25. Southeast Asia Medical Collagen Market Outlook, by End User, 2020-2033
    • 6.6.26. Rest of SAO Medical Collagen Market Outlook, by Source, 2020-2033
    • 6.6.27. Rest of SAO Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 6.6.28. Rest of SAO Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 6.6.29. Rest of SAO Medical Collagen Market Outlook, by Type, 2020-2033
    • 6.6.30. Rest of SAO Medical Collagen Market Outlook, by End User, 2020-2033
  • 6.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America Medical Collagen Market Outlook, 2020 - 2033

  • 7.1. Latin America Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 7.1.1. Bovine Collagen
    • 7.1.2. Porcine Collagen
    • 7.1.3. Marine Collagen
    • 7.1.4. Poultry Collagen
    • 7.1.5. Others
  • 7.2. Latin America Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 7.2.1. Gelatin
    • 7.2.2. Hydrolyzed Collagen
    • 7.2.3. Native Collagen
    • 7.2.4. Others
  • 7.3. Latin America Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
    • 7.3.1. Powder
    • 7.3.2. Gel
    • 7.3.3. Films & Sheets
    • 7.3.4. Suspensions
    • 7.3.5. Liquid, Solid, Semi-solid
  • 7.4. Latin America Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
    • 7.4.1. Injectable Collagen
    • 7.4.2. Topical Collagen
    • 7.4.3. Bioabsorbable Collagen
  • 7.5. Latin America Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Specialty Clinics
    • 7.5.3. Pharmaceutical & Biotechnology Companies
    • 7.5.4. Research Institutes & CROs
  • 7.6. Latin America Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.6.1. Brazil Medical Collagen Market Outlook, by Source, 2020-2033
    • 7.6.2. Brazil Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 7.6.3. Brazil Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 7.6.4. Brazil Medical Collagen Market Outlook, by Type, 2020-2033
    • 7.6.5. Brazil Medical Collagen Market Outlook, by End User, 2020-2033
    • 7.6.6. Mexico Medical Collagen Market Outlook, by Source, 2020-2033
    • 7.6.7. Mexico Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 7.6.8. Mexico Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 7.6.9. Mexico Medical Collagen Market Outlook, by Type, 2020-2033
    • 7.6.10. Mexico Medical Collagen Market Outlook, by End User, 2020-2033
    • 7.6.11. Argentina Medical Collagen Market Outlook, by Source, 2020-2033
    • 7.6.12. Argentina Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 7.6.13. Argentina Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 7.6.14. Argentina Medical Collagen Market Outlook, by Type, 2020-2033
    • 7.6.15. Argentina Medical Collagen Market Outlook, by End User, 2020-2033
    • 7.6.16. Rest of LATAM Medical Collagen Market Outlook, by Source, 2020-2033
    • 7.6.17. Rest of LATAM Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 7.6.18. Rest of LATAM Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 7.6.19. Rest of LATAM Medical Collagen Market Outlook, by Type, 2020-2033
    • 7.6.20. Rest of LATAM Medical Collagen Market Outlook, by End User, 2020-2033
  • 7.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Medical Collagen Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 8.1.1. Bovine Collagen
    • 8.1.2. Porcine Collagen
    • 8.1.3. Marine Collagen
    • 8.1.4. Poultry Collagen
    • 8.1.5. Others
  • 8.2. Middle East & Africa Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 8.2.1. Gelatin
    • 8.2.2. Hydrolyzed Collagen
    • 8.2.3. Native Collagen
    • 8.2.4. Others
  • 8.3. Middle East & Africa Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
    • 8.3.1. Powder
    • 8.3.2. Gel
    • 8.3.3. Films & Sheets
    • 8.3.4. Suspensions
    • 8.3.5. Liquid, Solid, Semi-solid
  • 8.4. Middle East & Africa Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
    • 8.4.1. Injectable Collagen
    • 8.4.2. Topical Collagen
    • 8.4.3. Bioabsorbable Collagen
  • 8.5. Middle East & Africa Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Specialty Clinics
    • 8.5.3. Pharmaceutical & Biotechnology Companies
    • 8.5.4. Research Institutes & CROs
  • 8.6. Middle East & Africa Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.6.1. GCC Medical Collagen Market Outlook, by Source, 2020-2033
    • 8.6.2. GCC Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 8.6.3. GCC Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 8.6.4. GCC Medical Collagen Market Outlook, by Type, 2020-2033
    • 8.6.5. GCC Medical Collagen Market Outlook, by End User, 2020-2033
    • 8.6.6. South Africa Medical Collagen Market Outlook, by Source, 2020-2033
    • 8.6.7. South Africa Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 8.6.8. South Africa Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 8.6.9. South Africa Medical Collagen Market Outlook, by Type, 2020-2033
    • 8.6.10. South Africa Medical Collagen Market Outlook, by End User, 2020-2033
    • 8.6.11. Egypt Medical Collagen Market Outlook, by Source, 2020-2033
    • 8.6.12. Egypt Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 8.6.13. Egypt Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 8.6.14. Egypt Medical Collagen Market Outlook, by Type, 2020-2033
    • 8.6.15. Egypt Medical Collagen Market Outlook, by End User, 2020-2033
    • 8.6.16. Nigeria Medical Collagen Market Outlook, by Source, 2020-2033
    • 8.6.17. Nigeria Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 8.6.18. Nigeria Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 8.6.19. Nigeria Medical Collagen Market Outlook, by Type, 2020-2033
    • 8.6.20. Nigeria Medical Collagen Market Outlook, by End User, 2020-2033
    • 8.6.21. Rest of Middle East Medical Collagen Market Outlook, by Source, 2020-2033
    • 8.6.22. Rest of Middle East Medical Collagen Market Outlook, by Product Type, 2020-2033
    • 8.6.23. Rest of Middle East Medical Collagen Market Outlook, by Physical Form, 2020-2033
    • 8.6.24. Rest of Middle East Medical Collagen Market Outlook, by Type, 2020-2033
    • 8.6.25. Rest of Middle East Medical Collagen Market Outlook, by End User, 2020-2033
  • 8.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Collagen Solutions plc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. DSM Biomedical
    • 9.4.3. Integra LifeSciences Holdings Corporation
    • 9.4.4. Smith & Nephew plc
    • 9.4.5. Zimmer Biomet Holdings, Inc.
    • 9.4.6. Medtronic plc
    • 9.4.7. Baxter International Inc.
    • 9.4.8. Johnson & Johnson
    • 9.4.9. Stryker Corporation
    • 9.4.10. CollPlant Biotechnologies Ltd.
    • 9.4.11. Advanced BioMatrix, Inc.
    • 9.4.12. Nitta Gelatin Inc.
    • 9.4.13. Gelita AG
    • 9.4.14. Rousselot
    • 9.4.15. Koken Co., Ltd.

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기